Valeant seeks new chief to replace Pearson

Subscribe Today

Valeant Pharmaceuticals International is seeking a new chief executive officer to replace Michael Pearson. The news comes less than a month after the troubled pharmaceutical company said Pearson had returned to the post following his recovery from a severe case of pneumonia.